177 related articles for article (PubMed ID: 35238275)
1. Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma.
Gradel KO; Larsen TS; Frederiksen H; Vinholt PJ; Iachina M; Póvoa P; Zampieri FG; Nielsen SL; Dessau RB; Møller JK; Jensen TG; Chen M; Coia JE; Jelicic J
Ann Med; 2022 Dec; 54(1):713-722. PubMed ID: 35238275
[No Abstract] [Full Text] [Related]
2. Utility of a simple prognostic stratification based on platelet counts and serum albumin levels in elderly patients with diffuse large B cell lymphoma.
Ochi Y; Kazuma Y; Hiramoto N; Ono Y; Yoshioka S; Yonetani N; Matsushita A; Imai Y; Hashimoto H; Ishikawa T
Ann Hematol; 2017 Jan; 96(1):1-8. PubMed ID: 27641425
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Troppan KT; Schlick K; Deutsch A; Melchardt T; Egle A; Stojakovic T; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Pichler M
Br J Cancer; 2014 Jul; 111(1):55-60. PubMed ID: 24874478
[TBL] [Abstract][Full Text] [Related]
4. Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma.
Cao Y; Shi YX; Chen JO; Tan YT; Cai YC; Luo HY; Qiu MZ; Cai XY; Jin Y; Sun YL; Jiang WQ
Tumour Biol; 2012 Aug; 33(4):1039-44. PubMed ID: 22328138
[TBL] [Abstract][Full Text] [Related]
5. Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.
Bairey O; Shacham-Abulafia A; Shpilberg O; Gurion R
Hematol Oncol; 2016 Dec; 34(4):184-192. PubMed ID: 26052918
[TBL] [Abstract][Full Text] [Related]
6. Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma.
Wei Y; Wei X; Huang W; Song J; Zheng J; Zeng H; Liu J; Zhan M; Wei Q; Feng R
Int J Hematol; 2020 May; 111(5):681-685. PubMed ID: 31993938
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of international prognostic index, revised international prognostic index, enhanced international prognostic index and Grupo Español de Linfomas/trasplante autólogo de médula ósea-international prognostic index for diffuse large B-cell lymphoma].
Feng YX; Su LP
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):949-954. PubMed ID: 33256307
[No Abstract] [Full Text] [Related]
8. Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma.
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):671-9. PubMed ID: 26361646
[TBL] [Abstract][Full Text] [Related]
9. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of hepatitis C virus infection in patients with diffuse large B-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index.
Chen YY; Huang CE; Liang FW; Lu CH; Chen PT; Lee KD; Chen CC
Cancer Epidemiol; 2015 Jun; 39(3):382-7. PubMed ID: 25899771
[TBL] [Abstract][Full Text] [Related]
11. The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma.
Yang Y; Wang L; Ma Y; Han T; Huang M
Am J Med Sci; 2017 May; 353(5):459-465. PubMed ID: 28502332
[TBL] [Abstract][Full Text] [Related]
12. Clinical risk scores do not accurately identify a very high risk population with diffuse large B cell lymphoma-an analysis of 386 Portuguese patients.
Coutinho R; Lobato J; Esteves S; Cabeçadas J; Gomes da Silva M
Ann Hematol; 2019 Aug; 98(8):1937-1946. PubMed ID: 30949752
[TBL] [Abstract][Full Text] [Related]
13. An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.
Sun F; Zhu J; Lu S; Zhen Z; Wang J; Huang J; Ding Z; Zeng M; Sun X
BMC Cancer; 2018 Jan; 18(1):5. PubMed ID: 29291712
[TBL] [Abstract][Full Text] [Related]
14. Useful prognostic tools based on complete blood cell counts in diffuse large B-cell lymphoma.
Shimono J; Takahashi S; Takemura R; Kakinoki Y
Int J Lab Hematol; 2019 Dec; 41(6):754-761. PubMed ID: 31529774
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
Panizo C; Rodríguez AJ; Gutiérrez G; Díaz FJ; González-Barca E; de Oña R; Grande C; Sancho JM; García-Álvarez MF; Sánchez-González B; Peñalver FJ; Cannata J; Espeso M; Requena MJ; Gardella S; Durán S; González AP; Alfonso A; Caballero MD;
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):398-403. PubMed ID: 25843416
[TBL] [Abstract][Full Text] [Related]
16. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
17. The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China.
Li X; Zhang Y; Zhao W; Liu Z; Shen Y; Li J; Shen Z
Ann Hematol; 2015 Jan; 94(1):57-63. PubMed ID: 25085376
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
Huang H; Fan L; Fu D; Lin Q; Shen J
Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic value of the international prognostic index, the national comprehensive cancer network IPI and the age-adjusted IPI in diffuse large B cell lymphoma].
Song JL; Wei XL; Zhang YK; Hao XX; Huang WM; Wei Q; Wei YQ; Feng R
Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):739-744. PubMed ID: 30369184
[No Abstract] [Full Text] [Related]
20. Low serum cholesterol levels predict inferior prognosis and improve NCCN-IPI scoring in diffuse large B cell lymphoma.
Gao R; Liang JH; Wang L; Zhu HY; Wu W; Cao L; Fan L; Li JY; Yang T; Xu W
Int J Cancer; 2018 Oct; 143(8):1884-1895. PubMed ID: 29744861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]